MedPath

SANDOZ RIOCIGUAT

SANDOZ RIOCIGUAT

Approved
DIN Number

02533618

Drug Class

Human

Market Date

Apr 29, 2024

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02533618
AIG Number0154770005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C02KX05 RIOCIGUAT
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification48:48.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

RIOCIGUATActive
Strength: 2.5 MG
Monograph: RIOCIGUAT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.